Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of TRAK2 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of TRAK2 mRNA | affects expression | 21346803
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of TRAK2 mRNA | affects expression | 21346803
|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in decreased expression of TRAK2 mRNA | decreases expression | 16514628
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of TRAK2 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TRAK2 mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TRAK2 mRNA | decreases expression | 20018196
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of TRAK2 mRNA | increases expression | 20382639
|
D004958 |
Estradiol |
Estradiol results in increased expression of TRAK2 mRNA | increases expression | 16514628
|
C070081 |
fulvestrant |
fulvestrant results in decreased expression of TRAK2 mRNA | decreases expression | 16514628
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of TRAK2 mRNA | increases expression | 16671099
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of TRAK2 mRNA | decreases expression | 16514628
|
D014501 |
Uranium |
Uranium affects the expression of TRAK2 mRNA | affects expression | 15672453
|
C005460 |
uranyl acetate |
uranyl acetate affects the expression of TRAK2 mRNA | affects expression | 15672453
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of TRAK2 mRNA | increases expression | 19101580
|
C025643 |
vinclozolin |
vinclozolin affects the expression of TRAK2 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
8.89 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.89 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.96 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.72 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
4.72 | 10697514 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.63 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.55 | 15800139 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.30 | 17688650 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.91 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
8.93 | 17497229 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
8.93 | 19015723 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.88 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 18396377 18775368 18316065 18177632 17688650 20603192 19460635 16609825 19232924 18985861 17507914 18558336 17157402 15238991 18940202 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.09 | 17594078 20046352 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.42 | 8888407 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.52 | 16580743 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.38 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.07 | 12948864 17261762 16675129 17018787 17289903 14630087 19861407 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
2.07 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
2.07 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.07 | 17440819 17595753 15758505 16837676 17261762 17893378 17952589 16912660 15775269 15572757 17049068 17242785 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.51 | 16111702 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.93 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.93 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
8.93 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
8.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
8.93 | 16270382 17159502 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
3.18 | 16274795 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.10 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.46 | 15775269 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
7.47 | 14694615 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.47 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.28 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.28 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.28 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
5.53 | 16154183 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.72 | 20734317 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.66 | 15800139 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.68 | 17273769 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
4.18 | 15095906 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.89 | 16575769 17688650 8888407 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.38 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.04 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.04 | 18551238 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.19 | 17474826 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
9.09 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.09 | 15920148 17451421 17308373 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.12 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.12 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
12.12 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.12 | 12392966 11461765 14986274 10915739 11834606 14725611 12594235 11287661 12540782 19416960 19420014 10663392 17562736 18071297 18713872 17906064 19164858 12705907 11529661 19739265 16393943 12153990 19370779 16781746 14550746 10774834 16109766 19085960 16485898 11421492 15619225 12958197 16081117 16227642 15968718 16177239 17522070 11743745 11739529 19923254 2444490 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.12 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.16 | 19426721 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.08 | 1851702 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.37 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
4.03 | 15845917 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
7.84 | 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.84 | 19148513 11473722 18566989 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.19 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.98 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.95 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.61 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.34 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.11 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.08 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
8.14 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.14 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.95 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.17 | 8888407 18558336 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.74 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.98 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.36 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
3.91 | 16187019 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.55 | 11110106 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.09 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.81 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.92 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.72 | 16870215 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.87 | 15787275 17577099 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
7.19 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
7.19 | 16467254 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.98 | 16393666 16627594 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
5.94 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.94 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.54 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.54 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
12.54 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.53 | 16973256 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.15 | 17596541 16294345 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
6.11 | 16707609 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.78 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
1.68 | 14659978 14716833 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.63 | 11587558 12969438 19014921 16610002 12587719 16611625 19784758 19460945 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.26 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.16 | 7678174 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.56 | 6135515 2876784 2876786 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.32 | 17228818 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.38 | 17203775 16891317 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
6.38 | 10697514 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.55 | 19453300 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
2.83 | 16270382 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.61 | 19513568 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.21 | 18765137 18803445 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.62 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
4.34 | 16274795 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.46 | 16497877 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.06 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.17 | 17596541 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.30 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.62 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.52 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.52 | 18551238 7678174 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
3.31 | 17353921 15958647 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.78 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.69 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.14 | 16359493 8888407 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.89 | 18514411 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.73 | 16303764 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
15.32 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
15.32 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
15.32 | 14694615 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.41 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.26 | 15758505 15579764 17823083 17893378 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.16 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
5.16 | 16133793 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.41 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
3.36 | 15580305 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.89 | 20603192 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
9.89 | 18220299 18042343 19015723 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.98 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.91 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.71 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
2.71 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.71 | 16536755 15731164 16220300 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.98 | 18629315 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.60 | 11422049 12752131 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.62 | 15770314 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.42 | 16303925 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.21 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.93 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.93 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.93 | 17978042 14763951 1511512 16876388 11044598 15475178 11738929 3137016 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
3.50 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.80 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.60 | 12833885 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.84 | 16837676 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.92 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.92 | 19048282 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.30 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.57 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
12.07 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
12.07 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
12.07 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
12.07 | 17572228 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.68 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.16 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.16 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.01 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
4.59 | 16154183 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.27 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.62 | 16343187 |